2026-04-17T06:36:14Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/2203602025-12-05T04:20:28Zcom_2072_1057col_2072_478809col_2072_478917

00925njm 22002777a 4500 dc Darbà, Josep author Ascanio, Meritxell author 2025-04-09T08:15:53Z 2025-04-09T08:15:53Z 2025-04-01 2025-04-09T08:15:53Z Hepatocellular carcinoma (HCC), which accounts for about 90% of all primary liver can-cer cases, is the fifth most common malignancy and the second leading cause of cancer-related mor-tality worldwide. This study aims to analyse the differential costs of HCC-related hospital admissionscompared to the general population in Spain (...) Hepatologia Control de costos Carcinogènesi Economia de la salut Política sanitària Hepatology Cost control Carcinogenesis Medical economics Medical policy Hepatocellular carcinoma: what are the differential costs compared to the general population?